Table 2 Clinical and pathological characteristics of BCLM
Clinicopathological characteristics | Total (n = 270) (proportion, %) |
|---|---|
Age (years, mean ± SD) | 50 ± 8.7 |
Gender | |
Female | 270 (100%) |
Group | |
BCLMs were found in the first examination | 8 (3%) |
BCLMs were found by follow-up | 262 (97%) |
Pathology | |
Invasive ductal carcinoma | 263 (97.4%) |
Invasive lobular carcinoma | 2 (0.7%) |
Ductal carcinoma in situ | 3 (1.1%) |
Mucinous carcinoma | 1 (0.4%) |
Neuroendocrine carcinoma | 1 (0.4%) |
Molecular types | |
Luminal A | 30 (11%) |
Luminal B | 157 (58%) |
HER-2 | 41 (15%) |
Basal-like | 42 (16%) |